Physician profile
Michael Lang
NPI 1518950807
$793.88
in general payments reported to CMS, 2019-2025
17 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.47 · 2020: $39.15 · 2021: $27.39 · 2022: $141 · 2023: $241 · 2024: $133 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.84 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $110.29 | 2019-2024 | |
| Glaxosmithkline, LLC. | $88.16 | 2020-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $66.15 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $39.86 | 2020-2022 | |
| Amgen INC. | $33.54 | 2020-2023 | Repatha, Otezla |
| Dexcom, INC. | $33.20 | 2023-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $29.68 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $24.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.38 | 2023 | Ofev |
| Ultragenyx Pharmaceutical INC. | $21.22 | 2024 | Crysvita |
| Xeris Pharmaceuticals, INC. | $20.78 | 2023 | Gvoke Hypopen |
| Abbott Laboratories | $20.76 | 2024 | Freestyle Libre 3 |
| Shield Therapeutics INC | $18.73 | 2023 | Accrufer |
| Sanofi Pasteur INC. | $16.33 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.10 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.